Pancreatic Cancer Research

ResearcherChinese PLA General HospitalActive in the last 2 years

Shiyun Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7976-9335; OpenAlex author ID A5089191243. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy. First author DOI 10.3389/fimmu.2025.1487318↗
  2. Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy. First author DOI 10.1080/21645515.2024.2376429↗
  3. Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer. Co-author DOI 10.1080/21645515.2023.2252692↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guanghai Dai · 3 shared papers, 2023–2025 · strength 0.90
  2. Yue Ma · 1 shared paper, 2024 · strength 0.36
  3. Ru Jia · 1 shared paper, 2025 · strength 0.30
  4. Nan Zhang · 1 shared paper, 2025 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.